J&J Asked Rival Companies to Join Blood Clot Research– Only AstraZeneca Accepted
Video Credit: Veuer - Duration: 01:01s - Published
J&J Asked Rival Companies to Join Blood Clot Research– Only AstraZeneca Accepted
A report by The Wall Street Journal revealed that Johnson & Johnson privately asked AstraZeneca, Moderna and Pfizer to join them in evaluating the risk of blood clots in the Covid-19 vaccine.
Veuer’s Johana Restrepo has more.
